Osteoblastic differentiation of human adult mesenchymal stem cells after Ad-BMP-2 in the absence of dexamethasone;Osteoblastäre differenzierung von humanen adulten mesenchymalen stammzellen durch transgenes BMP-2 in abwesenheit von dexamethason

Zeitschrift fur Orthopadie und Ihre Grenzgebiete

Volumn 143, Issue 6, 2005, Pages 684-690

  Koch, Hannjörg ^a   Jadlowiec, J A ^b   Whalen, J D ^c   Robbins, P ^d   Lattermann, C ^e   Fu, F H ^e   Merk, H R ^a   Hollinger, J O ^b  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b CARNEGIE MELLON UNIVERSITY   (United States)

^c UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Adenoviral transduction; BMP 2; Human mesenchymal stem cells; Osteoblastic differentiation; Quantitative real time PCR

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; DEXAMETHASONE; RECOMBINANT PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ADENOVIRUS; ANALYSIS OF VARIANCE; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; GENE EXPRESSION; GENE TRANSFER; GENOTYPE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHENOTYPE; POLYMERASE CHAIN REACTION; POST HOC ANALYSIS;

ADULT; BONE MORPHOGENETIC PROTEINS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; HUMANS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; RECOMBINANT PROTEINS; TISSUE ENGINEERING; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 29944436830     PISSN: 00443220     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-918186     Document Type: Article

References (46)

1. Osyczka AM, Leboy PS. Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signal-regulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 2005; 146: 3428-3437
2. Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol 1976; 4: 267-274
3. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147
4. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71-74
5. Jager M, Wild A, Fuss M, Werner A, Krauspe R. [Advantages of biomatrices in chondrogenesis of pluripotent mesenchymal stem]. Z Orthop Ihre Grenzgeb 2002; 140: 681-689
6. Koch H, Jadlowiec JA, Fu FH, Nonn J, Merk HR, Hollinger JO, Campbell PG. [The effect of growth/differentiation factor-5 (GDF-5) on genotype and phenotype in human adult mesenchymal stem cells]. Z Orthop Ihre Grenzgeb 2004; 142: 248-253
7. Niemeyer P, Krause U, Punzel M, Fellenberg J, Simank HG. [Mesenchymal stem cells for tissue engineering of bone: 3D-cultivation and osteogenic differentiation on mineralized collagen]. Z Orthop Ihre Grenzgeb 2003; 141: 712-717
8. Shin M, Yoshimoto H, Vacanti JP. In vivo bone tissue engineering using mesenchymal stem cells on a novel electrospun nanofibrous scaffold. Tissue Eng 2004; 10: 33-41
9. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990; 143: 420-430
10. Wozney JM, Rosen V, Celeste AJ, Mitsock LM, Whitters MJ, Kriz RW, Hewick RM, Wang EA. Novel regulators of bone formation: molecular clones and activities. Science 1988; 242: 1528-1534
11. Ducy P, Schinke T, Karsenty G. The osteoblast: a sophisticated fibroblast under central surveillance. Science 2000; 289: 1501-1504
12. Anderson HC, Sipe JB, Hessle L, Dhanyamraju R, Atti E, Camacho NP, Millan JL. Impaired calcification around matrix vesicles of growth plate and bone in alkaline phosphatase-deficient mice. Am J Pathol 2004; 164: 841-847
13. Baltzer AW, Whalen JD, Stefanovic-Racic M, Ziran B, Robbins PD, Evans CH. Adenoviral transduction of human osteoblastic cell cultures: a new perspective for gene therapy of bone diseases. Acta Orthop Scand 1999; 70: 419-424
14. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 2004; 176: 109-119
15. Jorgensen NR, Henriksen Z, Sorensen OH, Civitelli R. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 2004; 69: 219-226
16. Urist MR. Bone: formation by autoinduction. Science 1965; 150: 893-899
17. Schmitt JM, Hwang K, Winn SR, Hollinger JO. Bone morphogenetic proteins: an update on basic biology and clinical relevance. J Orthop Res 1999; 17: 269-278
18. Hartwig CH, Esenwein SA, Pfund A, Kusswetter Dagger W, Herr G. [Improved osseointegration of titanium implants of different surface characteristics by the use of bone morphogenetic protein (BMP-3): an animal study performed at the metaphyseal bone bed in dogs]. Z Orthop Ihre Grenzgeb 2003; 141: 705-711
19. Kessler S, Mayr-Wohlfart U, Ignatius A, Puhl W, Claes L, Gunther KP. [The impact of bone morphogenetic protein-2 (BMP-2), vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) on osseointegration, degradation and biomechanical properties of a synthetic bone substitute]. Z Orthop Ihre Grenzgeb 2003; 141: 472-480
20. Siebert CH, Miltner O, Schneider U, Weber M, Wahner T, Niedhart C. [Filling of osteochondral donor site defects. Experimental study with tricalcium phosphate cement and BMP-2]. Z Orthop Ihre Grenzgeb 2003; 141: 227-232
21. Baltzer AW, Liebau C. [Bone morphogenetic proteins - significance for biological bone healing]. Z Orthop Ihre Grenzgeb 1999; 137: 9-10
22. Boden SD. Clinical application of the BMPs. J Bone Joint Surg [Am] 2001; 83 (Suppl 1 Pt 2): S161
23. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schnettler R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdenk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg [Am] 2002; 84: 2123-2134
24. Diefenderfer DL, Osyczka AM, Reilly GC, Leboy PS. BMP responsiveness in human mesenchymal stem cells. Connect Tissue Res 2003; 4 (Suppl 1): 305-311
25. Chen TL. Inhibition of growth and differentiation of osteoprogenitors in mouse bone marrow stromal cell cultures by increased donor age and glucocorticoid treatment. Bone 2004; 35: 83-95
26. Jadlowiec J, Koch H, Zhang X, Campbell PG, Seyedain M, Sfeir C. Phosphophoryn regulates the gene expression and differentiation of NIH3T3, MC3T3-E1, and human mesenchymal stem cells via the integrin/MAPK signaling pathway. J Biol Chem 2004; 279: 53323-53330
27. Evans CH, Ghivizzani SC, Robbins PD. Orthopaedic gene therapy. Clin Orthop 2004; 429: 316-329
28. Niyibizi C, Baltzer A, Lattermann C, Oyama M, Whalen JD, Robbins PD, Evans CH. Potential role for gene therapy in the enhancement of fracture healing. Clin Orthop 1998; 355 (Suppl): S148-S153
29. Partridge K, Yang X, Clarke NM, Okubo Y, Bessho K, Sebald W, Howdle SM, Shakesheff KM, Oreffo RO. Adenoviral BMP-2 gene transfer in mesenchymal stem cells: in vitro and in vivo bone formation on biodegradable polymer scaffolds. Biochem Biophys Res Commun 2002; 292: 144-152
30. Turgeman G, Pittman DD, Muller R, Kurkalli BG, Zhou S, Pelled G, Peyser A, Zilberman Y, Moutsatsos IK, Gazit D. Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy. J Gene Med 2001; 3: 240-251
31. Robbins PD, Ghivizzani SC. Viral vectors for gene therapy. Pharmacol Ther 1998; 80: 35-47
32. AppliedBiosystems. User Bulletin #2: ABI Prism 7700 Sequence Detection System: Applied Biosystems, Foster City, CA; updated 10/2001
33. Koch H, Jadlowiec J, Whalen J, Lattermann C, Robbins P, Fu FH, Merk HR, Hollinger JO. [Refined Adenoviral Transduction for Controlled Gene Transfer into Human Adult Mesenchymal Stem Cells]. Z Orthop Ihre Grenzgeb 2005; im Druck
34. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997; 64: 278-294
35. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 1997; 64: 295-312
36. Lian JB, Shalhoub V, Aslam F, Frenkel B, Green J, Hamrah M, Stein GS, Stein JL. Species-specific glucocorticoid and 1,25-dihydroxyvitamin D responsiveness in mouse MC3T3-E1 osteoblasts: dexamethasone inhibits osteoblast differentiation and vitamin D down-regulates osteocalcin gene expression. Endocrinology 1997; 138: 2117-2127
37. Abe E, Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas SC. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 2000; 15: 663-673
38. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997; 89: 747-754
39. Ducy P, Starbuck M, Priemel M, Shen J, Pinero G, Geoffroy V, Amling M, Karsenty G. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development. Genes Dev 1999; 13: 1025-1036
40. Nakashima K, Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer RR, de Crombrugghe B. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 2002; 108: 17-29
41. Centrella M, Horowitz MC, Wozney JM, McCarthy TL. Transforming growth factor-beta gene family members and bone. Endocr Rev 1994; 15: 27-39
42. Rodan GA. Introduction to bone biology. Bone 1992; 13 (Suppl 1): S3-S6
43. Koch H, Jadlowiec J, Campbell PG. Adenoviral-delivered IGF-1 induces early commitment to osteogenic lineage in primary human adult mesenchymal stem cells. Stem Cells Dev 2005; im Druck
44. Evans CH, Robbins PD. Possible orthopaedic applications of gene therapy. J Bone Joint Surg [Am] 1995; 77: 1103-1114
45. Lehrman S. Virus treatment questioned after gene therapy death. Nature 1999; 401: 517-518
46. Kaiser J. Gene therapy. Seeking the cause of induced leukemias in X-SCID trial. Science 2003; 299: 495